| Gene symbol | ROR2 | Synonyms | BDB, BDB1, NTRKR2 | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9q22.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | receptor tyrosine kinase like orphan receptor 2 | ||||
| GTO ID | GTC1849 |
| Trial ID | NCT03393936 |
| Disease | Renal Cell Carcinoma |
| Altered gene | ROR2 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | CAR-T cell |
| Treatment | CCT301-59|CCT301-38 |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma |
| Year | 2018 |
| Country | China |
| Company sponsor | Shanghai PerHum Therapeutics Co., Ltd. |
| Other ID(s) | CCT301-mRCC01 |
| Cohort 1 | |||||||||||||
|
|||||||||||||